In 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033, with a CAGR of 10.45% during the forecast period 2023-2033.

The key factors driving growth include a rise in the incidence of chronic diseases leading to organ failure increases in the use of transplant diagnostics, increase in the adoption of stem cell therapy and incidences of leukemia leading to an upsurge in demand for transplant diagnostics tests, advantages of developing advanced molecular and genomic technologies in the transplant diagnostics, and presence of favorable regulatory scenario including reimbursement schemes.

Market Lifecycle Stage

The global organ transplant diagnostics market is in the developed phase. The development of non-invasive techniques for monitoring transplant recipients using NGS and advancements in human leukocyte antigen (HLA) typing tests for an organ transplant are some of the major opportunities in the global organ transplant diagnostics market.

Impact of COVID-19

The COVID-19 pandemic impacted the healthcare segment in different ways. The organ transplant segment of the industry got highly impacted by the pandemic, as the focus of hospitals and ambulatory centers shifted toward the affected patients. Moreover, as a method of prevention, surgeries got delayed, which had a significant effect on organ transplant procedures and on organ transplant diagnostics tests.

Market Segmentation:

Segmentation 1: by Offering

•    Products
•    Services

The global organ transplant diagnostics market (by offering) is expected to be dominated by the services segment.

Segmentation 2: by Transplant Type

•    Solid Organ Transplant
•    Stem Cell Transplant

The global organ transplant diagnostics market (by transplant type) is expected to be dominated by the solid organ transplant segment.

Segmentation 3: by Application

•    Diagnostics
•    Translational Research

The global organ transplant diagnostics market (by application) is expected to be dominated by the diagnostics segment.

Segmentation 4: by Technology

•    Molecular Technologies
•    Non-Molecular Technologies
•    Other Technologies

The global organ transplant diagnostics market (by technology) is expected to be dominated by the molecular technologies segment.

Segmentation 5: by End User

•    Hospitals and Transplant Centers
•    Academic and Research Institutions
•    Reference Laboratories
•    Other End Users

The global organ transplant diagnostics market (by end user) is expected to be dominated by the hospitals and transplant centers segment.

Segmentation 6: by Region

•    North America – U.S., Canada
•    Europe – Germany, U.K., France, Italy, Spain, Switzerland, and Rest-of-Europe
•    Asia-Pacific – China, Japan, India, Australia, South Korea, Singapore, and Rest-of-Asia-Pacific
•    Latin America – Brazil, Mexico, and Rest-of-Latin America
•    Rest-of-the-World

The global organ transplant diagnostics market (by region) is dominated by the North America region.

Recent Developments in the Global Organ Transplant Diagnostics Market

•    In April 2023, bioMérieux S.A. and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics, which would also lead to the development of infectious disease tests used during transplantation.
•    In April 2023, CareDx and Miromatrix announced an exclusive partnership to advance research using bioengineered organs for human transplantation.
•    In December 2022, GenDx partnered with Azure Biosystems, a leading provider of innovative bioanalytical solutions for protein and genomic research, to demonstrate the compatibility of the Azure Cielo 6 qPCR System with the GenDx KMRtype and KMRtrack kits.
•    In November 2022, Bio-Rad Laboratories and NuProbe USA signed a licensing agreement for digital PCR assay development. The technology would advance Bio-Rad’s portfolio.
•    In October 2022, Eurobio Scientific finalized the purchase of a 100% stake in Genome Diagnostics BV (GenDx) in a deal valued at $132.3 million.
•    In September 2022, BioMAdvanced Diagnostics announced fundraising of $1.3 million. The fundraising would allow BioMAdvanced Diagnostics to finalize the design of its first products and to start two clinical studies, one on the rejection of kidney transplants and the other on the lung.
•    In September 2022, BioMAdvanced Diagnostics announced the launch of Design Freeze of its IVD test for transplant kidney rejection.
•    In September 2022, GenDx announced that it signed a non-exclusive service agreement with Oxford Nanopore Technologies (Oxford Nanopore) to bring its new NGS-Turbo product to the transplant market for high-resolution HLA typing.

Demand – Drivers and Limitations

Following are the drivers for the Global Organ Transplant Diagnostics market:

•    Rise in the Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics
•    Increase in the Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests
•    Advantages of Developing Advanced Molecular and Genomic Technologies in the Transplant Diagnostics Tests
•    Presence of Favorable Regulatory Scenario Including Reimbursement Schemes

The market is expected to face some limitations as well due to the following challenges:

•    Increased Gap in Organ Donation and Organ Transplant Demand, which Hinders the Growth of the Organ Transplant Diagnostics Market
•    High Cost of Investment for Transplant Diagnostics Tests

How can this report add value to an organization?

Offerings: The offerings segment helps the reader understand the different manufacturers and service providers available in the market for organ transplant diagnostics. Moreover, the study provides the reader with a detailed understanding of transplant types and applications.

Growth/Marketing Strategy: The global organ transplant diagnostics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been synergistic activities such as partnerships, collaborations, expansions, and funding activities. For instance, in April 2023, bioMérieux S.A. and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics, which will also lead to the development of infectious disease tests used during transplantation.

Competitive Strategy: The key players in the global organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the global organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Key Companies Profiled

Manufacturers
•    Abbott Laboratories
•    BAG Group GmbH
•    bioMérieux S.A.
•    Bio-Rad Laboratories, Inc.
•    Eurobio Scientific
•    F. Hoffmann-La Roche Ltd.
•    Illumina, Inc.
•    Immucor, Inc.
•    Omixon Inc.
•    QIAGEN N.V.
•    Thermo Fisher Scientific Inc.

Service Providers
•    ARUP Laboratories
•    CareDx, Inc.
•    Laboratory Corporation of America Holdings
•    Quest Diagnostics Incorporated

Table of Contents

1 Product Definition
1.1 Inclusion and Exclusion Criteria
2 Market Scope
2.1 Scope of Work
2.2 Key Questions Answered in the Report:
3 Research Methodology
3.1 Global Organ Transplant Diagnostics Market: Research Methodology
3.2 Data Sources
3.2.1 Primary Data Sources
3.2.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Criteria for Company Profiling
4 Global Organ Transplant Diagnostics Market: Overview
4.1 Current Market Scenario
4.1.1 For Researchers
4.1.2 For Diagnostics
4.2 Market Footprint
4.3 COVID-19 Impact on Market
4.3.1 Impact on Operations
4.3.2 COVID-19 Impact: Current Scenario of Market
4.3.3 Pre- and Post-COVID-19 Impact Assessment
4.3.3.1 Pre-COVID-19 Phase
4.3.3.2 Post-COVID-19 Phase
5 Global Organ Transplant Diagnostics Market: Industry Analysis
5.1 Overview
5.2 Legal Requirements and Regulatory Frameworks in the U.S.
5.2.1 U.S. FDA Regulation
5.2.2 CMS Regulation
5.3 Legal Requirements and Framework in Europe
5.4 Legal Requirements and Framework in Asia-Pacific
5.4.1 China
5.4.2 Japan
5.5 Reimbursement Scenario
5.6 Patent Analysis
5.6.1 Patent Filing Trend (by Country)
5.6.2 Patent Filing Trend (by Year)
6 Global Organ Transplant Diagnostics Market: Market Dynamics
6.1 Impact Analysis
6.2 Market Drivers
6.2.1 Rise in Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics
6.2.2 Increase in Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests
6.2.3 Presence of Favorable Regulatory Scenarios including Reimbursement Schemes for Some Organ Transplant Diagnostics
6.2.4 Advantages of Developing Advanced Molecular and Genomic Technologies in Transplant Diagnostics Tests
6.3 Market Restraints
6.3.1 Increased Gap in Organ Donation and Organ Transplant Demand Hinders the Growth of Organ Transplant Diagnostics Market
6.3.2 High Cost of Investment for Transplant Diagnostics Tests Acts as a Barrier to Growth of the Market
6.4 Market Opportunities
6.4.1 Development of Non-Invasive Techniques for Monitoring Transplant Recipients using NGS
6.4.2 Advancements in Human Leukocyte Antigen (HLA) Typing Tests for Organ Transplant
7 Competitive Insights
7.1 Overview
7.2 Key Strategies and Development
7.2.1 Synergistic Activities
7.2.2 Product and Service Launches
7.2.3 Product Approvals
7.2.4 Acquisitions and Mergers
7.2.5 Regulatory Accreditions
7.3 Market Share Analysis 2021 vs. 2022
7.4 Growth-Share Analysis
7.4.1 By Company
8 Global Organ Transplant Diagnostics Market: (by Offering)
8.1 Overview
8.2 Products
8.2.1 Kits and Assays
8.2.2 Consumables
8.3 Services
9 Global Organ Transplant Diagnostics Market: (by Transplant Type)
9.1 Overview
9.2 Solid Organ Transplant
9.2.1 Kidney
9.2.2 Liver
9.2.3 Lung
9.2.4 Pancreas
9.2.5 Other Organs Transplant
9.3 Stem Cell Transplant
10 Global Organ Transplant Diagnostics Market: (by Application)
10.1 Overview
10.2 Diagnostics
10.2.1 Donor Testing
10.2.1.1 Pre-Transplantation Testing
10.2.1.1.1 Histocompatibility Testing
10.2.1.1.2 Blood Profiling Testing
10.2.1.1.3 Other Testing
10.2.1.2 Post-Transplantation Testing
10.2.1.2.1 Post-Infection Testing
10.2.1.2.2 Risk of Disorder Testing
10.2.1.2.3 Other Testing
10.2.2 Recipient Testing
10.2.2.1 Pre-Transplantation Testing
10.2.2.1.1 Histocompatibility Testing
10.2.2.1.2 Blood Profiling Testing
10.2.2.1.3 Other Testing
10.2.2.2 Post-Transplantation Testing
10.2.2.2.1 Post-Infection Testing
10.2.2.2.2 Risk of Disorder Testing
10.2.2.2.3 Other Testing
10.3 Translational Research
11 Global Organ Transplant Diagnostics Market: (by Technology)
11.1 Overview
11.2 Molecular Technologies
11.2.1 PCR
11.2.2 Sanger Sequencing
11.2.3 Next-Generation Sequencing (NGS)
11.2.4 Other Molecular Technologies
11.3 Non-Molecular Technologies
11.3.1 Serology
11.3.2 Flow Cytometry
11.4 Other Technologies
12 Global Organ Transplant Diagnostics Market: (by End User)
12.1 Overview
12.2 Hospitals and Transplant Centers
12.3 Academic and Research Institutions
12.4 Reference Laboratories
12.5 Other End Users
13 Region
13.1 North America
13.1.1 North America Organ Transplant Test Volume, by Transplant Type
13.1.2 Market Sizing and Forecast
13.1.2.1 North America Organ Transplant Diagnostics Market (by Country)
13.1.2.1.1 U.S.
13.1.2.1.2 Canada
13.2 Europe
13.2.1 Europe Organ Transplant Test Volume, by Transplant Type
13.2.2 Market Sizing and Forecast
13.2.2.1 Europe Organ Transplant Diagnostics Market (by Country)
13.2.2.1.1 France
13.2.2.1.2 Spain
13.2.2.1.3 U.K.
13.2.2.1.4 Italy
13.2.2.1.5 Germany
13.2.2.1.6 Switzerland
13.2.2.1.7 Rest-of-Europe
13.3 Asia-Pacific
13.3.1 Asia-Pacific Organ Transplant Test Volume, by Transplant Type
13.3.2 Market Sizing and Forecast
13.3.2.1 Asia-Pacific Organ Transplant Diagnostics Market (by Country)
13.3.2.1.1 China
13.3.2.1.2 India
13.3.2.1.3 South Korea
13.3.2.1.4 Japan
13.3.2.1.5 Australia
13.3.2.1.6 Singapore
13.3.2.1.7 Rest-of-Asia-Pacific
13.4 Latin America
13.4.1 Latin America Organ Transplant Test Volume, by Transplant Type
13.4.2 Market Sizing and Forecast
13.4.2.1 Latin America Organ Transplant Diagnostics Market (by Country)
13.4.2.1.1 Brazil
13.4.2.1.2 Mexico
13.4.2.1.3 Rest-of-Latin America
13.5 Rest-of-the-World
13.5.1 Rest-of-the-World Organ Transplant Test Volume, by Transplant Type
13.5.2 Market Sizing and Forecast
14 Company Profiles
14.1 Overview
14.2 Manufacturers
14.2.1 Abbott Laboratories
14.2.1.1 Company Overview
14.2.1.2 Role of Abbott Laboratories in the Organ Transplant Diagnostics Market
14.2.1.3 Product Portfolio
14.2.1.4 Financials
14.2.1.5 Analyst Perception
14.2.2 BAG Group GmbH
14.2.2.1 Company Overview
14.2.2.2 Role of BAG Group GmbH in the Organ Transplant Diagnostics Market
14.2.2.3 Product Portfolio
14.2.2.4 Analyst Perception
14.2.3 bioMérieux S.A.
14.2.3.1 Company Overview
14.2.3.2 Role of bioMérieux S.A. in the Organ Transplant Diagnostics Market
14.2.3.3 Product Portfolio
14.2.3.4 Financials
14.2.3.5 Recent Developments
14.2.3.6 Analyst Perception
14.2.4 Bio-Rad Laboratories, Inc.
14.2.4.1 Company Overview
14.2.4.2 Role of Bio-Rad Laboratories, Inc. in the Organ Transplant Diagnostics Market
14.2.4.3 Product Portfolio
14.2.4.4 Financials
14.2.4.5 Recent Developments
14.2.4.6 Analyst Perception
14.2.5 Eurobio Scientific (Genome Diagnostics B.V.)
14.2.5.1 Company Overview
14.2.5.2 Role of Eurobio Scientific (Genome Diagnostics B.V.) in the Organ Transplant Diagnostics Market
14.2.5.3 Product Portfolio
14.2.5.4 Analyst Perception
14.2.6 F. Hoffmann-La Roche Ltd.
14.2.6.1 Company Overview
14.2.6.2 Role of F. Hoffmann-La Roche Ltd. in the Organ Transplant Diagnostics Market
14.2.6.3 Product Portfolio
14.2.6.4 Financials
14.2.6.5 Recent Developments
14.2.6.6 Analyst Perception
14.2.7 Illumina, Inc.
14.2.7.1 Company Overview
14.2.7.2 Role of Illumina, Inc. in the Organ Transplant Diagnostics Market
14.2.7.3 Product Portfolio
14.2.7.4 Financials
14.2.7.5 Analyst Perception
14.2.8 Immucor, Inc.
14.2.8.1 Company Overview
14.2.8.2 Role of Immucor, Inc. in the Organ Transplant Diagnostics Market
14.2.8.3 Product Portfolio
14.2.8.4 Analyst Perception
14.2.9 Omixon Inc.
14.2.9.1 Company Overview
14.2.9.2 Role of Omixon Inc. in the Organ Transplant Diagnostics Market
14.2.9.3 Product Portfolio
14.2.9.4 Analyst Perception
14.2.10 QIAGEN N.V.
14.2.10.1 Company Overview
14.2.10.2 Role of QIAGEN N.V. in the Organ Transplant Diagnostics Market
14.2.10.3 Product Portfolio
14.2.10.4 Financials
14.2.10.5 Recent Developments
14.2.10.6 Analyst Perception
14.2.11 Thermo Fisher Scientific Inc.
14.2.11.1 Company Overview
14.2.11.2 Role of Thermo Fisher Scientific Inc. in the Organ Transplant Diagnostics Market
14.2.11.3 Product Portfolio
14.2.11.4 Financials
14.2.11.5 Recent Developments
14.2.11.6 Analyst Perception
14.3 Service Providers
14.3.1 ARUP Laboratories
14.3.1.1 Company Overview
14.3.1.2 Role of ARUP Laboratories in the Organ Transplant Diagnostics Market
14.3.1.3 Product Portfolio
14.3.1.4 Analyst Perception
14.3.2 CareDx, Inc.
14.3.2.1 Company Overview
14.3.2.2 Role of CareDx, Inc. in the Organ Transplant Diagnostics Market
14.3.2.3 Product Portfolio
14.3.2.4 Financials
14.3.2.5 Recent Developments
14.3.2.6 Analyst Perception
14.3.3 Laboratory Corporation of America Holdings
14.3.3.1 Company Overview
14.3.3.2 Role of Laboratory Corporation of America Holdings in the Organ Transplant Diagnostics Market
14.3.3.3 Product Portfolio
14.3.3.4 Financials
14.3.3.5 Analyst Perception
14.3.4 Quest Diagnostics Incorporated
14.3.4.1 Company Overview
14.3.4.2 Role of Quest Diagnostics Incorporated in the Organ Transplant Diagnostics Market
14.3.4.3 Product Portfolio
14.3.4.4 Financials
14.3.4.5 Analyst Perception

List of Figures

Figure 1: Global Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 2: Global Organ Transplant Diagnostics Market, Impact Analysis
Figure 3: Global Organ Transplant Diagnostics Market (by Offering), Share (%), 2022 and 2033
Figure 4: Global Organ Transplant Diagnostics Market (by Transplant Type), Share (%), 2022 and 2033
Figure 5: Global Organ Transplant Diagnostics Market (by Application), Share (%), 2022 and 2033
Figure 6: Global Organ Transplant Diagnostics Market (by Technology), Share (%), 2022 and 2033
Figure 7: Global Organ Transplant Diagnostics Market (by End User), Share (%), 2022 and 2033
Figure 8: Global Organ Transplant Diagnostics Market (by Region), $Billion, 2022 and 2033
Figure 9: Global Organ Transplant Diagnostics Market Segmentation
Figure 10: Global Organ Transplant Diagnostics Market: Research Methodology
Figure 11: Primary Research Methodology
Figure 12: Bottom-Up Approach (Segment-Wise Analysis)
Figure 13: Top-Down Approach (Segment-Wise Analysis)
Figure 14: Global Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 15: Global Organ Transplant Diagnostics Market, Patent Analysis (by Country), January 2018-December 2022
Figure 16: Global Organ Transplant Diagnostics Market, Patent Analysis (by Year), January 2018-December 2022
Figure 17: Global Organ Transplant Diagnostics Market, Impact Analysis
Figure 18: New Liver Cirrhosis and Other Chronic Liver Diseases Cases, Thousand, 2017 and 2021
Figure 19: Global Number of Solid Organ Transplants, 2017-2021
Figure 20: Applications of Stem Cell Therapy
Figure 21: Number of Transplants Performed and Patients on the Waiting List (by Organ), 2022
Figure 22: Global Organ Transplant Diagnostics Market, Total Number of Key Developments, January 2018-April 2023
Figure 23: Synergistic Activities, January 2018-April 2023
Figure 24: Product and Service Launches, January 2018-April 2023
Figure 25: Product Approvals, January 2018-April 2023
Figure 26: Acquisitions and Mergers, January 2018-April 2023
Figure 27: Regulatory Accreditions, January 2018-April 2023
Figure 28: Global Organ Transplant Diagnostics Market, Market Share Analysis, %, 2021 and 2022
Figure 29: Global Organ Transplant Diagnostics Market, Growth-Share Matrix (by Company), 2022
Figure 30: Global Organ Transplant Diagnostics Market (by Offering)
Figure 31: Global Organ Transplant Diagnostics Market (Products), $Billion, 2022-2033
Figure 32: Global Organ Transplant Diagnostics Market (Kits and Assays), $Million, 2022-2033
Figure 33: Global Organ Transplant Diagnostics Market (Consumables), $Million, 2022-2033
Figure 34: Global Organ Transplant Diagnostics Market (Services), $Billion, 2022-2033
Figure 35: Global Organ Transplant Diagnostics Market (by Transplant Type)
Figure 36: Global Organ Transplant Diagnostics Market (Solid Organ Transplant), $Billion, 2022-2033
Figure 37: Global Organ Transplant Diagnostics Market (Kidney), $Billion, 2022-2033
Figure 38: Global Organ Transplant Diagnostics Market (Liver), $Million, 2022-2033
Figure 39: Global Organ Transplant Diagnostics Market (Lung), $Million, 2022-2033
Figure 40: Global Organ Transplant Diagnostics Market (Pancreas), $Million, 2022-2033
Figure 41: Global Organ Transplant Diagnostics Market (Other Organs Transplant), $Million, 2022-2033
Figure 42: Global Organ Transplant Diagnostics Market (Stem Cell Transplant), $Billion, 2022-2033
Figure 43: Global Organ Transplant Diagnostics Market (by Application)
Figure 44: Global Organ Transplant Diagnostics Market (Diagnostics), $Billion, 2022-2033
Figure 45: Global Organ Transplant Diagnostics Market (Donor Testing), $Billion, 2022-2033
Figure 46: Global Organ Transplant Diagnostics Market (Pre-Transplantation Testing), $Million, 2022-2033
Figure 47: Global Organ Transplant Diagnostics Market (Histocompatibility Testing), $Million, 2022-2033
Figure 48: Global Organ Transplant Diagnostics Market (Blood Profiling Testing), $Million, 2022-2033
Figure 49: Global Organ Transplant Diagnostics Market (Other Testing), $Million, 2022-2033
Figure 50: Global Organ Transplant Diagnostics Market (Post-Transplantation Testing), $Million, 2022-2033
Figure 51: Global Organ Transplant Diagnostics Market (Post-Infection Testing), $Million, 2022-2033
Figure 52: Global Organ Transplant Diagnostics Market (Risk of Disorder Testing), $Million, 2022-2033
Figure 53: Global Organ Transplant Diagnostics Market (Other Testing), $Million, 2022-2033
Figure 54: Global Organ Transplant Diagnostics Market (Recipient Testing), $Billion, 2022-2033
Figure 55: Global Organ Transplant Diagnostics Market (Pre-Transplantation Testing), $Million, 2022-2033
Figure 56: Global Organ Transplant Diagnostics Market (Histocompatibility Testing), $Million, 2022-2033
Figure 57: Global Organ Transplant Diagnostics Market (Blood Profiling Testing), $Million, 2022-2033
Figure 58: Global Organ Transplant Diagnostics Market (Other Testing), $Million, 2022-2033
Figure 59: Global Organ Transplant Diagnostics Market (Post-Transplantation Testing), $Billion, 2022-2033
Figure 60: Global Organ Transplant Diagnostics Market (Post-Infection Testing), $Million, 2022-2033
Figure 61: Global Organ Transplant Diagnostics Market (Risk of Disorder Testing), $Million, 2022-2033
Figure 62: Global Organ Transplant Diagnostics Market (Other Testing), $Million, 2022-2033
Figure 63: Global Organ Transplant Diagnostics Market (Translational Research), $Million, 2022-2033
Figure 64: Global Organ Transplant Diagnostics Market (by Technology)
Figure 65: Global Organ Transplant Diagnostics Market (Molecular Technologies), $Billion, 2022-2033
Figure 66: Global Organ Transplant Diagnostics Market (PCR), $Million, 2022-2033
Figure 67: Global Organ Transplant Diagnostics Market (Sanger Sequencing), $Million, 2022-2033
Figure 68: Global Organ Transplant Diagnostics Market (Next-Generation Sequencing), $Million, 2022-2033
Figure 69: Global Organ Transplant Diagnostics Market (Other Molecular Technologies), $Million, 2022-2033
Figure 70: Global Organ Transplant Diagnostics Market (Non-Molecular Technologies), $Billion, 2022-2033
Figure 71: Global Organ Transplant Diagnostics Market (Serology), $Billion, 2022-2033
Figure 72: Global Organ Transplant Diagnostics Market (Flow Cytometry), $Million, 2022-2033
Figure 73: Global Organ Transplant Diagnostics Market (Other Technologies), $Million, 2022-2033
Figure 74: Global Organ Transplant Diagnostics Market (by End User)
Figure 75: Global Organ Transplant Diagnostics Market (Hospitals and Transplant Centers), $Billion, 2022-2033
Figure 76: Global Organ Transplant Diagnostics Market (Academic and Research Institutions), $Billion, 2022-2033
Figure 77: Global Organ Transplant Diagnostics Market (Reference Laboratories), $Million, 2022-2033
Figure 78: Global Organ Transplant Diagnostics Market (Other End Users), $Million, 2022-2033
Figure 79: Global Organ Transplant Diagnostics Market Share and CAGR (by Region), 2022 and 2023-2033
Figure 80: North America Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 81: North America Organ Transplant Diagnostics Market (by Country), Share (%), 2023 and 2033
Figure 82: U.S. Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 83: Canada Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 84: Europe Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 85: Europe Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033
Figure 86: France Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 87: Spain Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 88: U.K. Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 89: Italy Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 90: Germany Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 91: Switzerland Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 92: Rest-of-Europe Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 93: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
Figure 94: Asia-Pacific Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033
Figure 95: China Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 96: India Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 97: South Korea Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 98: Japan Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 99: Australia Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 100: Singapore Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 101: Rest-of-Asia-Pacific Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 102: Latin America Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 103: Latin America Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033
Figure 104: Brazil Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 105: Mexico Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 106: Rest-of-Latin America Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 107: Rest-of-the-World Organ Transplant Diagnostics Market, $Million, 2022-2033
Figure 108: Total Number of Companies Profiled
Figure 109: Global Organ Transplant Diagnostics Market Overview, Key Companies
Figure 110: Abbott Laboratories: Product Portfolio
Figure 111: Abbott Laboratories: Overall Financials, $Billion, 2020-2022
Figure 112: Abbott Laboratories: Net Revenue (by Business Segment), $Billion, 2020-2022
Figure 113: Abbott Laboratories: Net Revenue (by Region), $Billion, 2020-2022
Figure 114: Abbott Laboratories: R&D Expenditure, $Billion, 2020-2022
Figure 115: BAG Group GmbH: Overall Product Portfolio
Figure 116: bioMérieux S.A.: Overall Product Portfolio
Figure 117: bioMérieux S.A.: Overall Financials, $Million, 2019-2021
Figure 118: bioMérieux S.A.: Net Revenue (by Region), $Million, 2019-2021
Figure 119: bioMérieux S.A.: R&D Expenditure, $Million, 2019-2021
Figure 120: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 121: Bio-Rad Laboratories, Inc.: Overall Financials, $Billion, 2020-2022
Figure 122: Bio-Rad Laboratories, Inc.: Net Revenue (by Business Segment), $Million, 2020-2022
Figure 123: Bio-Rad Laboratories, Inc.: Net Revenue (by Region), $Million,  2020-2022
Figure 124: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 125: Eurobio Scientific (Genome Diagnostics B.V.): Overall Product Portfolio
Figure 126: F. Hoffmann-La Roche Ltd.: Overall Product Portfolio
Figure 127: F. Hoffmann-La Roche Ltd.: Overall Financials, $Billion, 2020-2022
Figure 128: F. Hoffmann-La Roche Ltd.: Net Revenue (by Business Segment), $Billion, 2020-2022
Figure 129: F. Hoffmann-La Roche Ltd.: Diagnostics Revenue (by Region), $Billion, 2020-2022
Figure 130: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Billion, 2020-2022
Figure 131: Illumina, Inc.: Overall Product Portfolio
Figure 132: Illumina, Inc.: Overall Financials, $Million, 2020-2022
Figure 133: Illumina, Inc.: Net Revenue (by Business Segment), $Million, 2020-2022
Figure 134: Illumina, Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 135: Illumina, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 136: Immucor, Inc.: Product Portfolio
Figure 137: Omixon Inc.: Overall Product Portfolio
Figure 138: QIAGEN N.V.: Product Portfolio
Figure 139: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
Figure 140: QIAGEN N.V.: Net Revenue (by Business Segment), $Million, 2019-2021
Figure 141: QIAGEN N.V.: Net Revenue (by Region), $Million, 2019-2021
Figure 142: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
Figure 143: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 144: Thermo Fisher Scientific Inc.: Overall Financials, $Billion, 2020-2022
Figure 145: Thermo Fisher Scientific Inc.: Net Revenue (by Business Segment), $Billion, 2020-2022
Figure 146: Thermo Fisher Scientific Inc.: Net Revenue (by Region), $Billion,2020-2022
Figure 147: Thermo Fisher Scientific Inc.: R&D Expenditure, $Billion, 2020-2022
Figure 148: ARUP Laboratories: Overall Product Portfolio
Figure 149: CareDx, Inc.: Overall Product Portfolio
Figure 150: CareDx, Inc.: Overall Financials, $Million, 2020-2022
Figure 151: CareDx, Inc.: Net Revenue (by Business Segment), $Million, 2020-2022
Figure 152: CareDx, Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 153: CareDx, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 154: Laboratory Corporation of America Holdings: Overall Product Portfolio
Figure 155: Laboratory Corporation of America Holdings: Overall Financials, $Billion, 2020-2022
Figure 156: Laboratory Corporation of America Holdings: Net Revenue (by Business Segment), $Billion, 2020-2022
Figure 157: Quest Diagnostics Incorporated: Product Portfolio
Figure 158: Quest Diagnostics Incorporated: Overall Financials, $Billion, 2020-2022
Figure 159: Quest Diagnostics Incorporated: Net Revenue (by Business Segment), $Billion, 2020-2022

List of Tables

Table 1: Key Questions Answered in the Report
Table 2: Key Coverage Providers for Organ Transplant Diagnostics Tests
Table 3: North America Organ Transplant Diagnostics Market, Impact Analysis
Table 4: North America Organ Transplant Test Volume, by Transplant Type, 2021
Table 5: Europe Organ Transplant Diagnostics Market, Impact Analysis
Table 6: Europe Organ Transplant Test Volume, by Transplant Type, 2021
Table 7: Asia-Pacific Organ Transplant Diagnostics Market, Impact Analysis
Table 8: Asia-Pacific Organ Transplant Test Volume, by Transplant Type, 2021
Table 9: Latin America Organ Transplant Diagnostics Market, Impact Analysis
Table 10: Latin America Organ Transplant Test Volume, by Transplant Type, 2021
Table 11: Rest-of-the-World Organ Transplant Diagnostics Market, Impact Analysis
Table 12: Rest-of-the-World Organ Transplant Test Volume, by Transplant Type, 2021

The post Organ Transplant Diagnostics Market – A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and Country Analysis – Analysis and Forecast, 2023-2033 first appeared on CRI Report.

Market Overview

The 6G market is supposed to enroll the most noteworthy CAGR of 28.10% during the conjecture time frame. Before long, 6G innovation is supposed to develop as another rendition of the worldwide versatile norm, adding new abilities to 5G, and 4G/LTE administrations. At first, the developing requirement for 6G correspondence across businesses and high accentuation on low idleness networks for explicit applications are driving the development of the market.

When contrasted with the 5G organization, the 6G organization is anticipated to give a 100x expansion in energy and volumetric unearthly proficiency. In view of the immense interconnectedness, the 6G framework will be really troublesome. Somewhere in the range of 2020 and 2030, worldwide portable information traffic is anticipated to move by 55% each year. To meet these prerequisites and dreams for the future, the critical drivers of the generational jump past present portable correspondence frameworks would be a blend of cultural necessities and innovation leap forwards that improve those necessities.

In the end, 6G will greatly affect how we carry on with work, work, deal with our local area frameworks, and live, as will the development of any remaining advancements. 6G’s commitment is based on detecting, which is vital to interfacing with the actual climate and mimicking it, stretching out to independent vehicles, savvy production lines, and accurate medical care, and that’s just the beginning. However, with excellent information rates and low idleness, 6G will give secure dependability, dexterity, and dynamic experiences to help new and creative applications in remote availability, cognizance, detecting, and imaging.

Market Segmentation

In this study, the 6G market has been divided into three categories based on component types hardware, software, and services.

Based on communication infrastructure, the 6G market has been divided into two categories in this report: fixed and wireless.

Multisensory XR Applications, Connected Robotics and Autonomous Systems (CRAS), Wireless Brain-Computer Interactions (BCI), Digital Twins, Smart Cities, Internet of Everything (IoE), and Others make up the application-based segmentation of the 6G market.

This report’s segmentation of the 6G market according to end users includes.

Regional Analysis

Geologically, North America is anticipated to represent the most elevated extent of the 6G Market because of the region’s significant presence of significant organizations, government drives, and various different reasons. With regards to advancing the up-and-coming age of correspondence innovation, the US is disappointing.

AT&T and Ericsson chiefs were chosen to lead a US industry body’s work to advance North America as an innovator in 6G organizations. Canadians depend on a decent Web association for work, school, cash, and medical care like never before previously, making admittance to great and reasonable administrations basic. Accordingly, the Canadian government is making range open to advanced rivalry, rustic availability, and the powerful arrangement of Wi-Fi and 5G innovations.

The Asia Pacific region is anticipated to have the best development in the 6G Market because of the area’s expanded accentuation on satellite correspondence and enhancements in this industry. China has sent off the world’s most memorable 6G test satellite into space, extraordinarily expanding market interest.

On November 2021, the Division of Broadcast communications laid out an Innovation Development Gathering on 6G (TIG-6G) with individuals from different Services/Divisions, innovative work foundations, the scholarly world, normalization bodies, telecom specialist organizations, and industry to foster a Dream, Mission, and Objectives for 6G, as well as a guide and activity plans for 6G in India.

Major Players

Key Companies in the 6G Market are SAMSUNG ELECTRONICS, TELEFONAKTIEBOLAGET LM ERICSSON, NOKIA, HUAWEI TECHNOLOGIES CO. LTD., AT&T INC., LG ELECTRONICS, HPE, NTT DOCOMO INC., ZTE CORPORATION, JIO INFOCOMM LTD., QUALCOMM TECHNOLOGIES, INC., KEYSIGHT TECHNOLOGIES, T-MOBILE, CIENA CORPORATION, and INTEL CORPORATION.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 23

1.1 MARKET ATTRACTIVENESS ANALYSIS 25

2 MARKET INTRODUCTION 26

2.1 DEFINITION 26

2.2 SCOPE OF THE STUDY 26

2.3 RESEARCH OBJECTIVE 26

2.4 MARKET STRUCTURE 27

3 RESEARCH METHODOLOGY 28

4 MARKET DYNAMICS 35

4.1 INTRODUCTION 35

4.2 DRIVERS 36

4.2.1 GROWING NEED FOR 6G COMMUNICATION 36

4.2.2 HIGH EMPHASIS ON LOW LATENCY NETWORK FOR SPECIFIC APPLICATIONS 37

4.2.3 CAPITALIZING ON THE LATEST TECHNOLOGICAL ADVANCEMENTS 37

4.2.4 DRIVERS IMPACT ANALYSIS 38

4.3 RESTRAINTS 38

4.3.1 EXCESSIVE POWER CONSUMPTION 38

4.4 OPPORTUNITIES 39

4.4.1 USAGE OF HOLOGRAPHY IN COMMUNICATION 39

5 MARKET DYNAMICS 40

5.1 VALUE CHAIN ANALYSIS 40

5.1.1 NEXT-GENERATION BROADBAND 41

5.1.2 REAL-TIME CONTROL 41

5.1.3 PERVASIVE ACCESS 41

5.1.4 SOCIETAL SUSTAINABILITY 41

5.1.5 IMMERSIVE PLATFORM AND SERVICES 41

5.1.6 SPATIAL PERCEPTION 41

5.2 PORTER’S FIVE FORCES MODEL 43

5.2.1 THREAT OF NEW ENTRANTS 43

5.2.2 BARGAINING POWER OF SUPPLIERS 44

5.2.3 THREAT OF SUBSTITUTES 44

5.2.4 BARGAINING POWER OF BUYERS 44

5.2.5 INTENSITY OF RIVALRY 44

6 6G TECHNOLOGY OUTLOOK 45

6.1 GLOBAL 6G TECHNOLOGY RESEARCH 52

6.2 KEY TECHNOLOGY ELEMENTS OF 6G 56

6.2.1 NETWORK ADAPTABILITY 56

6.2.2 ENHANCED, END-TO-END CONNECTIVITY 57

6.2.3 EXTREME PERFORMANCE AND COVERAGE 58

6.2.4 EMBEDDED DEVICES EVERYWHERE 59

6.2.5 COGNITIVE NETWORKS 59

6.2.6 NETWORK COMPUTE FABRIC 60

6.2.7 TRUSTWORTHY SYSTEMS 61

6.3 6G TECHNOLOGY PATENTS SCENARIO 62

6.4 6G TECHNOLOGY ALLIANCES 67

6.4.1 NEXT G ALLIANCE (US) 67

6.4.2 HEXA – X (EUROPE) 67

6.4.3 TIG-6G (INDIA) 67

6.4.4 IMT-2030 PG (CHINA) 68

6.4.5 IOWN AND BEYOND 5G (JAPAN) 68

6.4.6 6G NATIONAL STRATEGY – 5G FORUM (SOUTH KOREA) 68

7 GLOBAL 6G MARKET, BY COMPONENT 69

7.1 OVERVIEW 69

7.1.1 GLOBAL 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 70

7.2 HARDWARE 70

7.3 SOFTWARE 70

7.4 SERVICES 70

8 GLOBAL 6G MARKET, BY COMMUNICATION INFRASTRUCTURE 71

8.1 OVERVIEW 71

8.1.1 GLOBAL 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 72

8.2 WIRELESS 72

8.2.1 GLOBAL 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 72

8.2.2 MOBILE CELLULAR 72

8.2.3 MOBILE BROADBAND 73

8.3 FIXED 73

9 GLOBAL 6G MARKET, BY APPLICATION 74

9.1 OVERVIEW 74

9.1.1 GLOBAL 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 75

9.2 MULTISENSORY XR APPLICATIONS 75

9.3 CONNECTED ROBOTICS AND AUTONOMOUS SYSTEMS (CRAS) 75

9.4 WIRELESS BRAIN-COMPUTER INTERACTIONS (BCI) 76

9.5 DIGITAL TWINS 76

9.6 SMART CITIES 76

9.7 INTERNET OF EVERYTHING (IOE) 77

9.8 BLOCKCHAIN AND DLT 77

9.9 OTHERS 77

10 GLOBAL 6G MARKET, BY END USER 78

10.1 OVERVIEW 78

10.1.1 GLOBAL 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 79

10.2 GOVERNMENT 79

10.3 CONSUMER 79

10.4 INDUSTRIAL 79

10.5 ENTERPRISE 80

11 GLOBAL 6G MARKET, BY REGION 81

11.1 OVERVIEW 81

11.1.1 GLOBAL 6G MARKET, BY REGION, 2028–2040 (USD MILLION) 81

11.1.2 GLOBAL 6G MARKET, BY REGION, 2028–2040 (USD MILLION) 82

11.2 NORTH AMERICA 83

11.2.1 NORTH AMERICA: 6G MARKET, BY COUNTRY, 2028–2040 (USD MILLION) 84

11.2.2 NORTH AMERICA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 85

11.2.3 NORTH AMERICA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 86

11.2.3.1 NORTH AMERICA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 86

11.2.4 NORTH AMERICA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 87

11.2.5 NORTH AMERICA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 87

11.2.6 US 88

11.2.6.1 US 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 88

11.2.6.2 US 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 88

11.2.6.2.1 US 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 88

11.2.6.3 US 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 89

11.2.6.4 US 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 89

11.2.7 CANADA 89

11.2.7.1 CANADA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 89

11.2.7.2 CANADA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 90

11.2.7.2.1 CANADA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 90

11.2.7.3 CANADA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 90

11.2.7.4 CANADA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 91

11.2.8 MEXICO 91

11.2.8.1 MEXICO 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 91

11.2.8.2 MEXICO 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 91

11.2.8.2.1 MEXICO 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 91

11.2.8.3 MEXICO 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 92

11.2.8.4 MEXICO 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 92

11.3 EUROPE 93

11.3.1 EUROPE: 6G MARKET, BY COUNTRY, 2028–2040 (USD MILLION) 95

11.3.2 EUROPE 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 95

11.3.3 EUROPE 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 96

11.3.3.1 EUROPE 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 96

11.3.4 EUROPE 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 97

11.3.5 EUROPE 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 98

11.3.6 GERMANY 98

11.3.6.1 GERMANY 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 98

11.3.6.2 GERMANY 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 99

11.3.6.2.1 GERMANY 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 99

11.3.6.3 GERMANY 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 99

11.3.6.4 GERMANY 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 100

11.3.7 UK 100

11.3.7.1 UK 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 100

11.3.7.2 UK 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 100

11.3.7.2.1 UK 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 101

11.3.7.3 UK 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 101

11.3.7.4 UK 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 101

11.3.8 FRANCE 102

11.3.8.1 FRANCE 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 102

11.3.8.2 FRANCE 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 102

11.3.8.2.1 FRANCE 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 102

11.3.8.3 FRANCE 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 103

11.3.8.4 FRANCE 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 103

11.3.9 ITALY 103

11.3.9.1 ITALY 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 103

11.3.9.2 ITALY 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 104

11.3.9.2.1 ITALY 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 104

11.3.9.3 ITALY 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 104

11.3.9.4 ITALY 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 105

11.3.10 REST OF EUROPE 105

11.3.10.1 REST OF EUROPE 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 105

11.3.10.2 REST OF EUROPE 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 105

11.3.10.2.1 REST OF EUROPE 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 106

11.3.10.3 REST OF EUROPE 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 106

11.3.10.4 REST OF EUROPE 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 106

11.4 ASIA-PACIFIC 107

11.4.1 ASIA-PACIFIC: 6G MARKET, BY COUNTRY, 2028–2040 (USD MILLION) 109

11.4.2 ASIA-PACIFIC 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 109

11.4.3 ASIA-PACIFIC 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 110

11.4.3.1 ASIA-PACIFIC 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 110

11.4.4 ASIA-PACIFIC 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 111

11.4.5 ASIA-PACIFIC 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 112

11.4.6 CHINA 112

11.4.6.1 CHINA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 112

11.4.6.2 CHINA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 113

11.4.6.2.1 CHINA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 113

11.4.6.3 CHINA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 113

11.4.6.4 CHINA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 114

11.4.7 JAPAN 114

11.4.7.1 JAPAN 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 114

11.4.7.2 JAPAN 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 114

11.4.7.2.1 JAPAN 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 114

11.4.7.3 JAPAN 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 115

11.4.7.4 JAPAN 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 115

11.4.8 INDIA 115

11.4.8.1 INDIA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 115

11.4.8.2 INDIA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 116

11.4.8.2.1 INDIA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 116

11.4.8.3 INDIA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 116

11.4.8.4 INDIA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 117

11.4.9 SOUTH KOREA 117

11.4.9.1 SOUTH KOREA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 117

11.4.9.2 SOUTH KOREA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 117

11.4.9.2.1 SOUTH KOREA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 117

11.4.9.3 SOUTH KOREA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 118

11.4.9.4 SOUTH KOREA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 118

11.4.10 AUSTRALIA 118

11.4.10.1 AUSTRALIA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 118

11.4.10.2 AUSTRALIA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 119

11.4.10.2.1 AUSTRALIA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 119

11.4.10.3 AUSTRALIA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 119

11.4.10.4 AUSTRALIA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 120

11.4.11 REST OF ASIA-PACIFIC 120

11.4.11.1 REST OF ASIA-PACIFIC 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 120

11.4.11.2 REST OF ASIA-PACIFIC 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 120

11.4.11.2.1 REST OF ASIA-PACIFIC 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 121

11.4.11.3 REST OF ASIA-PACIFIC 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 121

11.4.11.4 REST OF ASIA-PACIFIC 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 121

11.5 MIDDLE EAST & AFRICA 122

11.5.1 MIDDLE EAST & AFRICA: 6G MARKET, BY COUNTRY, 2028–2040 (USD MILLION) 123

11.5.2 MIDDLE EAST & AFRICA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 124

11.5.3 MIDDLE EAST & AFRICA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 124

11.5.3.1 MIDDLE EAST & AFRICA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 125

11.5.4 MIDDLE EAST & AFRICA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 125

11.5.5 MIDDLE EAST & AFRICA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 126

11.5.6 SAUDI ARABIA 126

11.5.6.1 SAUDI ARABIA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 126

11.5.6.2 SAUDI ARABIA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 127

11.5.6.2.1 SAUDI ARABIA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 127

11.5.6.3 SAUDI ARABIA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 127

11.5.6.4 SAUDI ARABIA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 128

11.5.7 QATAR 128

11.5.7.1 QATAR 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 128

11.5.7.2 QATAR 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 128

11.5.7.2.1 QATAR 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 128

11.5.7.3 QATAR 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 129

11.5.7.4 QATAR 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 129

11.5.8 UAE 130

11.5.8.1 UAE 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 130

11.5.8.2 UAE 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 130

11.5.8.2.1 UAE 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 130

11.5.8.3 UAE 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 131

11.5.8.4 UAE 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 131

11.5.9 REST OF MIDDLE EAST & AFRICA 131

11.5.9.1 REST OF MIDDLE EAST & AFRICA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 131

11.5.9.2 REST OF MIDDLE EAST & AFRICA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 132

11.5.9.2.1 REST OF MIDDLE EAST & AFRICA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 132

11.5.9.3 REST OF MIDDLE EAST & AFRICA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 132

11.5.9.4 REST OF MIDDLE EAST & AFRICA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 133

11.6 SOUTH AMERICA 134

11.6.1 SOUTH AMERICA: 6G MARKET, BY COUNTRY, 2028–2040 (USD MILLION) 135

11.6.2 SOUTH AMERICA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 135

11.6.3 SOUTH AMERICA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 136

11.6.3.1 SOUTH AMERICA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 136

11.6.4 SOUTH AMERICA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 137

11.6.5 SOUTH AMERICA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 138

11.6.6 BRAZIL 138

11.6.6.1 BRAZIL 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 138

11.6.6.2 BRAZIL 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 139

11.6.6.2.1 BRAZIL 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 139

11.6.6.3 BRAZIL 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 139

11.6.6.4 BRAZIL 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 140

11.6.7 ARGENTINA 140

11.6.7.1 ARGENTINA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 140

11.6.7.2 ARGENTINA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 140

11.6.7.2.1 ARGENTINA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 141

11.6.7.3 ARGENTINA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 141

11.6.7.4 ARGENTINA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 141

11.6.8 REST OF SOUTH AMERICA 142

11.6.8.1 REST OF SOUTH AMERICA 6G MARKET, BY COMPONENT, 2028–2040 (USD MILLION) 142

11.6.8.2 REST OF SOUTH AMERICA 6G MARKET, BY COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 142

11.6.8.2.1 REST OF SOUTH AMERICA 6G MARKET, BY WIRELESS COMMUNICATION INFRASTRUCTURE, 2028–2040 (USD MILLION) 142

11.6.8.3 REST OF SOUTH AMERICA 6G MARKET, BY APPLICATION, 2028–2040 (USD MILLION) 143

11.6.8.4 REST OF SOUTH AMERICA 6G MARKET, BY END USER, 2028–2040 (USD MILLION) 143

12 COMPETITIVE LANSCAPE 144

12.1 OVERVIEW 144

12.2 COMPETITIVE BENCHMARKING 147

12.3 RECENT DEVELOPMENTS 148

12.3.1 PRODUCT DEVELOPMENT/ PROJECT ANNOUNCEMENTS 148

12.3.2 PARTNERSHIPS/AGREEMENTS/CONTRACTS/COLLABORATIONS 150

13 COMPANY PROFILES 153

13.1 NOKIA 153

13.1.1 COMPANY OVERVIEW 153

13.1.2 FINANCIAL OVERVIEW 154

13.1.3 6G TARGETED TECHNOLOGY OFFERINGS 154

13.1.4 KEY DEVELOPMENTS 155

13.1.5 SWOT ANALYSIS 155

13.1.6 KEY STRATEGIES 156

13.2 SAMSUNG ELECTRONICS 157

13.2.1 COMPANY OVERVIEW 157

13.2.2 FINANCIAL OVERVIEW 158

13.2.3 6G TARGETED TECHNOLOGY OFFERINGS 158

13.2.4 KEY DEVELOPMENTS 159

13.2.5 SWOT ANALYSIS 159

13.2.6 KEY STRATEGIES 159

13.3.1 COMPANY OVERVIEW 160

13.3.2 FINANCIAL OVERVIEW 161

13.3.3 6G TARGETED TECHNOLOGY OFFERINGS 161

13.3.4 KEY DEVELOPMENTS 162

13.3.5 SWOT ANALYSIS 162

13.3.6 KEY STRATEGIES 162

13.4 TELEFONAKTIEBOLAGET LM ERICSSON 163

13.4.1 COMPANY OVERVIEW 163

13.4.2 FINANCIAL OVERVIEW 164

13.4.3 6G TARGETED TECHNOLOGY OFFERINGS 164

13.4.4 KEY DEVELOPMENTS 165

13.4.5 SWOT ANALYSIS 165

13.4.6 KEY STRATEGIES 165

13.5 QUALCOMM TECHNOLOGIES, INC. 166

13.5.1 COMPANY OVERVIEW 166

13.5.2 FINANCIAL OVERVIEW 167

13.5.3 6G TARGETED TECHNOLOGY OFFERINGS 167

13.5.4 KEYDEVELOPMENTS 168

13.5.5 SWOT ANALYSIS 168

13.5.6 KEY STRATEGIES 168

13.6.1 COMPANY OVERVIEW 169

13.6.2 FINANCIAL OVERVIEW 170

13.6.3 6G TARGETED TECHNOLOGY OFFERINGS 170

13.6.4 KEY DEVELOPMENTS 171

13.6.5 SWOT ANALYSIS 171

13.6.6 KEY STRATEGIES 171

13.7.1 COMPANY OVERVIEW 172

13.7.2 FINANCIAL OVERVIEW 173

13.7.3 6G TARGETED TECHNOLOGY OFFERINGS 173

13.7.4 KEY DEVELOPMENTS 174

13.7.5 SWOT ANALYSIS 175

13.7.6 KEY STRATEGIES 175

13.8 HPE 176

13.8.1 COMPANY OVERVIEW 176

13.8.2 FINANCIAL OVERVIEW 177

13.8.3 SWOT ANALYSIS 178

13.8.4 KEY STRATEGIES 178

13.9 NTT DOCOMO INC. 179

13.9.1 COMPANY OVERVIEW 179

13.9.2 FINANCIAL OVERVIEW 180

13.9.3 KEY DEVELOPMENTS 181

13.9.4 KEY STRATEGIES 181

13.10 ZTE CORPORATION 182

13.10.1 COMPANY OVERVIEW 182

13.10.2 FINANCIAL OVERVIEW 183

13.10.3 KEY DEVELOPMENTS 184

13.10.4 SWOT ANALYSIS 185

13.10.5 KEY STRATEGIES 185

13.11 JIO INFOCOMM LTD. 186

13.11.1 COMPANY OVERVIEW 186

13.11.2 FINANCIAL OVERVIEW 187

13.11.3 KEY DEVELOPMENTS 188

13.11.4 KEY STRATEGIES 188

13.12 KEYSIGHT TECHNOLOGIES 189

13.12.1 COMPANY OVERVIEW 189

13.12.2 FINANCIAL OVERVIEW 190

13.12.3 6G TARGETED TECHNOLOGY OFFERINGS 190

13.12.4 KEY DEVELOPMENTS 190

13.12.5 SWOT ANALYSIS 191

13.12.6 KEY STRATEGIES 191

13.13 T-MOBILE 192

13.13.1 COMPANY OVERVIEW 192

13.13.2 FINANCIAL OVERVIEW 193

13.13.3 KEY DEVELOPMENTS 193

13.13.4 SWOT ANALYSIS 194

13.13.5 KEY STRATEGIES 194

13.14 CIENA CORPORATION 195

13.14.1 COMPANY OVERVIEW 195

13.14.2 FINANCIAL OVERVIEW 196

13.14.3 6G TARGETED TECHNOLOGY OFFERINGS 196

13.14.4 KEY DEVELOPMENTS 197

13.14.5 SWOT ANALYSIS 197

13.14.6 KEY STRATEGIES 197

13.15 INTEL CORPORATION 198

13.15.1 COMPANY OVERVIEW 198

13.15.2 FINANCIAL OVERVIEW 199

13.15.3 6G TARGETED TECHNOLOGY OFFERINGS 199

13.15.4 KEY DEVELOPMENTS 200

13.15.5 SWOT ANALYSIS 200

13.15.6 KEY STRATEGIES 200

The post 6G Market Research Report Forecast to 2040 first appeared on CRI Report.

The global smart harvest market was valued at $8,380.0 million in 2021 and is projected to reach $16,850.0 million by 2027, growing at a CAGR of 12.50% during the forecast period 2022-2027. The growth in the global smart harvest market is expected to be driven by the increasing adoption of smart agriculture practices, labor shortage in agriculture farms, and increasing need for sustainable agriculture.

Market Lifecycle Stage

The smart harvest market is in the introductory growth phase.

Increased research and development activities in agriculture, rising awareness of tech-based farming, and shortage and aging of agricultural workers in many countries are expected to increase the demand for smart harvesters such as robotic harvesters and automated tractors among farmers and other agriculture companies. Increasing crop production costs and increasing need for workforce automation are further supporting market growth.

Increasing adoption of robotic technology in agriculture practice and the implementation of several sensors as well as 3D imaging in smart farms are some of the major opportunities in the global smart harvest market. Moreover, the smart harvest market has huge opportunities in the Asia-Pacific region since most of the countries located in this region have huge agricultural sectors, which contribute to the nation’s GDP.

Impact

• North America generated the highest revenue of $2,290.0 million in 2021, which is expected to reach $4,540.0 million by 2027. The region has been experiencing rapid growth in the smart farming industry in the past few years owing to increasing technological advancements and increasing government support for the usage of smart equipment.

Owing to several benefits of smart farming, farmer and growers in this region are adopting different technologies on their farms, such as GPS, drones, robots, smart controllers, monitors, and others. All these factors are further influencing the market growth of smart harvest technologies in North America.

• Furthermore, Europe generated a revenue of $1,740.0 million in 2021 and is expected to grow at a CAGR of 10.37% from 2022 to 2027. High revenue generation was majorly attributed to increasing the use of smart farming systems and increasing investments from the European Commission for IoT-based smart farming. Most of the growth is expected to be driven by Eastern Europe countries in the forecast period.

Impact of COVID-19

The COVID-19 impact on the smart harvest market was there for a short term in 2020 and in 2021. However, the market is anticipated to witness robust growth and recovery with increasing demand for the installation of smart harvest equipment in agricultural farms throughout the world to make optimum utilization of resources with the shortage of skilled labor in the agriculture fields.

Hence, the demand for smart harvesters in the agriculture sector is expected to increase during and post-COVID-19 pandemic.

Market Segmentation:

Segmentation 1: by Application

• Site of Operation
o Controlled Environment Agriculture
o On-Field Agriculture
• Crop Type
o Fruits
o Vegetables
o Others

The global smart harvest market in the application segment has been segmented into the site of operation and crop type segments. Mostly smart harvesters are utilized in controlled environment agriculture to produce fresh fruits and vegetables under artificial conditions with limited labor. Autonomous tractors and other robotic harvesters are further used in the field to harvest cotton, apple, asparagus, and many other crops.

Segmentation 2: by Product

• Hardware
• Software
• Services

Among the three segments, the hardware segment is expected to dominate the global smart harvest market; in 2021, this segment was worth $6,645.0 million. The dominance of the hardware segment is due to the higher usage of robotic arms, robotic chassis, end-effectors, and automation systems, along with monitoring and sensing systems in smart harvest equipment.

Segmentation 3: by Region

• North America – U.S., Canada, Mexico, and Rest-of-North America
• Europe – Germany, Spain, France, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific – Japan, India, Australia, and Rest-of-Asia-Pacific
• South America – Brazil, Argentina, and Rest-of-South America
• Middle East and Africa – Turkey, South Africa, and Rest-of-Middle East and Africa

The Asia-Pacific region is the fastest-growing market in the smart harvest industry. The rapid change in the climatic conditions, increasing government support, rising need for food security, and increasing need for smart farming are the factors supporting the growth of smart harvest in the region.

Recent Developments in Global Smart Harvest Market

• In June 2022, Dogtooth Technologies introduced its latest fleet of strawberry-harvesting robots, mainly in the U.K. and Australia, to ease growers’ labor woes.

• In November 2021, Iron Ox launched Grover, an all-new autonomous mobile robot. Grover is a durable, hygienic as well as highly capable autonomous mobile robot that allows Iron Ox to save water, land, and energy.

• In November 2021, Fieldin acquired Midnight Robotics to advance its autonomous platforms. This acquisition was aimed at creating a brand-new sensor-based platform with driving technologies to improve the day-to-day management of the farm.

• In February 2019, OCTINION launched a strawberry-picking robot named Rubion. Rubion navigates through the strawberries, detects the ripe ones, picks the fruits without bruising, and places them in its punnet.

Demand – Drivers and Limitations

Following are the demand drivers for the smart harvest market:

• High Adoption of Smart Agriculture Technique to Optimize Crop Yield
• Need for Reducing Crop Production Cost
• Lack of Sufficient Workforce

The market is expected to face some limitations due to the following challenges:

• High Cost of Smart Harvesting Equipment
• Less Adoption among Small-Scale Farmers
• Technical Complexities Affecting Smart Harvest Adoption

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different types of smart harvest products available to be used in agriculture fields. Moreover, the study provides the reader with a detailed understanding of the different smart harvesters by application (controlled environment agriculture and on-field) and by component (hardware, software, and services).

The use of autonomous harvesters can solve the issue of labor shortage on farms and help in the selective harvesting of fruits, vegetables, and crops by reducing the wastage of produces. A combination of different technologies in the smart harvester, such as IoT, AI, sensors, monitors, 3D cameras, and robotic arms with end effectors, is making harvesting easy for farmers.

Growth/Marketing Strategy: The global smart harvest market has seen major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, and joint ventures. The favored strategy for the companies has been product launches to strengthen their position in the smart harvest market.

For instance, in January 2022, John Deere launched the new John Deere 8R autonomous robotic tractor. This tractor is suitable for large-scale production and will be available for farmers at the end of 2022. John Deere raised the bar for a new level of smart agriculture practice and agriculture autonomy from one of the most trusted as well as recognizable brands worldwide.

Competitive Strategy: Key players in the global smart harvest market analyzed and profiled in the study involve smart harvest manufacturers that provide different types of hardware and software to be used in autonomous harvesters.

Moreover, a detailed competitive benchmarking of the players operating in the global smart harvest market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The key market players are offering smart harvesters for controlled environment agriculture and on-filed agriculture. Autonomous tractors and smart harvesters are used on-field for harvesting crops such as cotton, nuts, wheat, hemp, and others.

These harvesters are fully automated and can automatically set harvesting schedules by collecting data from different software regarding the maturity of crops. Sometimes only one human labor is required along with the robotic harvester during the harvesting cycle.

Apart from saving the cost of labor, there are several advantages of using robotic harvesting. The on-field segment captured about 55.56% share in the global smart harvest market in 2021. Also, controlled environment agriculture captured about 44.44% share in the global smart harvest market. Indoor farms, aquaponic and hydroponic farms, vertical farms, greenhouses, nurseries, and hybrid farms come under controlled environment agriculture.

Most of these farms run with the help of artificial lights, humidifiers, sprinklers, controllers, monitors, drones, and robots. Since farmers and growers are looking for sustainable ways of agriculture, indoor farming or tech-based farming is gaining popularity. To reduce operational costs, these farms prefer robots to human labor for their operation. Hence, harvesting robots are quite beneficial for these farms.

Some of the established players in this market are:

Controlled Environment Agriculture: Companies Offering Smart Harvesters

• Agrobot
• Harvest Automation
• Iron Ox
• Dogtooth Technologies Limited
• MetoMotion
• Mycionics Inc.
• Panasonic Holdings Corporation
• TORTUGA AGRICULTURAL TECHNOLOGIES, INC.

On-Field: Companies Offering Smart Harvesters

• AVL Motion B.V.
• Harvest CROO
• Cerescon BV
• Deere & Company
• Energid Technologies Corporation
• FFRobotics
• Ripe Robotics
• Robert Bosch GmbH
• Vision Robotics Corporation

Companies that are not a part of the previous pool have been well represented across different sections of the report (wherever applicable).

The post Smart Harvest Market – A Global and Regional Analysis: Focus on Product and Application, Value Chain, and Country Analysis – Analysis and Forecast, 2022-2027 first appeared on CRI Report.

Market Segmentation

• Indication – Spinal Infections, Spinal Tumors, and Spinal Fractures
• End User – Hospitals and Clinics, Diagnostic Imaging Centers, and Ambulatory Surgery Centers
• Product – X-Ray Devices, CT Devices, and AI-Enabled X-Ray and CT Software
• Patient Type – Adults, and Pediatrics and Neonates

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific
• Rest-of-the-World – Brazil, Mexico, and Rest-of-Rest-of-the-World

Market Growth Drivers

• Increasing Prevalence of Spinal Injuries
• Advent of Artificial Intelligence in Medical Imaging
• Increasing Interest Among Venture Capitalists

Market Challenges

• Potential Risks Associated with Radiation Exposure
• Delay in Regulatory Approvals

Market Opportunities

• Development of AI-Based Digital X-Ray Systems
• High Growth Opportunity in Emerging Economies
• Leveraging Partnerships to Expand Business Opportunities

Key Companies Profiled

Agfa-Gevaert NV, Arterys, Inc., Carestream Health, Inc., Enlitic, Inc., Fujifilm Holdings Corporation, General Electric Company, Imagen Technologies, Inc., Infervision Medical Technology Co. Ltd., Koninklije Philips N.V., Nano-x Imaging LTD., Quibim, S.L., Qure.ai Technologies Pvt. Ltd., Siemens Healthineers AG, Shimadzu Corporation, Vuno Co., Ltd.

How This Report Can Add Value

Assuming that the reader is a manufacturer of X-ray and CT devices, the report will assist them in the following ways:

• Understand their position compared to other key players in the market
• Stay updated with novel technology integration, features, and the latest developments in the market
• Understand the impact of COVID-19 on X-ray and CT imaging and the entry barriers for new companies
• Gain insights into end-user perception concerning the spine X-ray and computed tomography market
• Identify some key players in the market and understand their valuable contribution

Key Questions Answered in the Report

• How has COVID-19 impacted the growth of the global spine X-ray and computed tomography market?
• What are the key regulations governing the spine X-ray and computed tomography market in key regions?
• What technological developments are projected to have the maximum influence on the global spine X-ray and computed tomography market?
• Who are the leading players holding significant dominance in the global spine X-ray and computed tomography market?
• What are some of the growth opportunities which market players can capitalize on?
• What are the drivers and restraints for the global spine X-ray and computed tomography market?
• Which region has the highest growth rate in the global spine X-ray and computed tomography market?
• Which are the fastest growing countries in terms of spine X-ray and CT g market?
• What are the key strategies being adopted by market players in the spine X-ray and computed tomography market?
• Which are the emerging companies in the global spine X-ray and computed tomography market?

Global Spine X-Ray and Computed Tomography (CT) Market Industry Overview

X-rays use electromagnetic radiation to produce images of internal tissues, bones, and tumors. CT scans are the imaging procedure that uses a combination of X-rays and computer technology to produce horizontal or axial images of the body. X-ray and CT devices are used by end markets such as hospitals, clinics, diagnostic imaging centers, and ambulatory surgical centers.

The market for spine X-ray and CT devices is rapidly growing, with an increasing number of X-rays and CT scans used in imaging of vertebral fractures, spinal infections, and spinal tumors, among others. Furthermore, the integration of AI in imaging has accelerated the growth of the market for factors such as rising healthcare costs, a lack of communication between physicians and patients, poor health conditions, a shortage of physicians and medical staff, and the rising prevalence of chronic health disorders. The global spine X-ray and computed tomography market is anticipated to grow rapidly owing to the advancements in the medical imaging industry with the constant demand to provide cost-effective and high-quality solutions in a shorter time period.

The global spine X-ray and computed tomography market report highlights that the market was valued at $916.0 million in 2020 and is expected to reach $1,623.5 million by the end of 2030. The market is expected to grow at a CAGR of 5.91% during the forecast period 2021-2030.

Global Spine X-Ray and Computed Tomography (CT) Market Drivers

The factors driving the growth of the market include an increasing number of spinal injuries driving the need for increased X-ray and CT scans, advent of artificial intelligence in medical imaging, and the growing expenditure in the healthcare industry. The increasing prevalence of falls, rising geriatric population has, in turn, increased the demand for procedural volume of X-rays and CT scans. Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.

Global Spine X-Ray and Computed Tomography (CT) Market Restraints

The factors restraining the growth of the global spine X-ray and computed tomography market include the risks associated with radiation exposure and delay in regulatory approvals. Delay in regulatory approval for the products due to the stringent government regulations concerning the use of AI-enabled software in medical imaging hinders the market’s growth. Moreover, another factor restraining the growth of the global spine X-ray and computed tomography market is the high cost associated with medical imaging.

Global Spine X-Ray and Computed Tomography (CT) Market Opportunities

High growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global spine X-ray and computed tomography market growth.

There is massive scope for spine X-ray and CT devices in developing countriesas countries such as China, India, Brazil, and Mexico possess populations with a high prevalence of spinal injuries and vertebral fractures. Thus, the rising prevalence of spinal injuries tends to increase the volume of X-ray and CT scans, consequently advancing device adoption and the growth of the global market.

Impact of COVID-19 on the Global Spine X-Ray and Computed Tomography (CT) Market

The COVID-19 pandemic had a debilitating impact on the global healthcare ecosystem. Hospitals and clinics faced several challenges such as lack of resources, high patient influx, and risk of infection among care providers. The market is projected to witness considerable growth during the forecast period 2021-2030. The increasing innovations and product designs in the global market and the growing use in emerging economies are the driving factors for the growth of the market.

Market Segmentation

Global Spine X-Ray and Computed Tomography (CT) Market (by Indication)

The global spine X-ray and computed tomography market, based on indication, has been segmented into spinal injuries, spinal tumors, and spinal fractures.

Spinal infections are caused by bacteria or fungi and affect the vertebral body, intervertebral disc, or paraspinal tissue. The increasing prevalence of spinal injuries is increasing the growth of the market as the diagnosis of spinal infections is a prolonged process with the usage of various imaging modalities.

Global Spine X-Ray and Computed Tomography (CT) Market (by Patient Type)

The global spine X-ray and computed tomography market, based on patient type, has been segmented into adults, and pediatrics and neonates. The injuries and fractures are caused by several factors such as falls, accidents, and sports injuries. The geriatric population is more susceptible to the injuries caused due to falls. Moreover, various guidelines and policies have been issued by regulatory bodies and agencies for dose safety in pediatric imaging.

Global Spine X-Ray and Computed Tomography (CT) Market (by End User)

The global spine X-ray and computed tomography market, based on end user, has been segmented into hospitals and clinics, diagnostic imaging centers, and ambulatory surgery centers surgical centers.

Hospitals and clinics are the major end users for the global spine X-ray and computed tomography market. The high volume of the end user makes them the primary diagnosis site for spinal injuries in emerging economies. Furthermore, the adoption of X-rays and CT in ASCs has been increased due to several factors such as personalized care to the patients and reduced recovery time.

Global Spine X-Ray and Computed Tomography (CT) Market (by Product)

The global spine X-ray and computed tomography market, based on product, has been segmented into X-ray devices, CT devices, and AI-enabled X-ray and CT software.

The X-ray devices segment is at the forefront of the spine X-ray and computed tomography market. The increasing focus on the inclusion of advanced technology such as AI and machine learning has been one of the strongest drivers for the growth of the X-ray devices segment.

Furthermore, the diagnosis using CT has greatly benefited from the advancements in AI during the past few years. AI-based solutions are presently being used extensively to interpret and prioritize to reduce the backlogs and the physician’s workload.

Global Spine X-Ray and Computed Tomography (CT) Market (by Region)

The different regions covered under the global spine X-ray and computed tomography market include North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America is expected to be the most lucrative region for the global spine X-ray and computed tomography market due to advanced healthcare infrastructure and a high focus on research and development activities. The Asia-Pacific spine X-ray and computed tomography market is one of the lucrative markets with immense potential for expansion by key players of the global spine X-ray and computed tomography market. The Asia-Pacific spine X-ray and computed tomography market is expected to grow at the fastest rate during the forecast period. This can be attributed to the massive geriatric population base, which is driving the increase in the volume of X-ray and CT scans.

Key Market Players and Competition Synopsis

Some key players operating in the global spine X-ray and computed tomography market include Agfa-Gevaert NV, Arterys, Inc., Carestream Health, Inc., Enlitic, Inc., Fujifilm Holdings Corporation, General Electric Company, Imagen Technologies, Inc., Infervision Medical Technology Co. Ltd., Koninklijke Philips N.V., Nano-x Imaging LTD., Quibim, S.L., Qure.ai Technologies Pvt. Ltd., Siemens Healthineers AG, Shimadzu Corporation, Vuno Co., Ltd.

Some strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, business expansion, regulatory and legal activities, and new offerings.

Related Reports: Global AI-Enabled X-Ray Imaging Solutions Market: Focus on Product Type, Workflow, Mode of Deployment, and Application, and 10 Country-Level Data – Analysis and Forecast, 2021-2031

The post Spine X-Ray and Computed Tomography (CT) Market – A Global and Regional Analysis: Focus on Applications, Product, End Users, and Country-Wise Analysis – Analysis and Forecast, 2021-2030 first appeared on CRI Report.